Nucleic Acid Labelling Market

Market Overview:

The global nucleic acid labelling market is expected to exhibit a growth rate (CAGR) of 8% during 2023-2028.

Nucleic acids refer to complex molecules that are used for transferring genetic information which directs all cellular functions. Some of the major types of these molecules include deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). These nucleic acids are generally labeled with tags to facilitate the identification and purification processes. Some of the most commonly used nucleic acid labeling techniques include the incorporation of radioactive phosphates, fluorescent tags and modifications with biotin. These chemical and enzymatic methods are widely used for a vast array of biotechnology and life sciences applications.

The market is primarily driven by the increasing utilization of nucleic acid-based diagnostics for disease risk management, disease diagnostics and prenatal testing across the healthcare sector. This is being supported by the rising incidences of genetic disorders across the globe which has impelled the demand for nucleic acid analytics in the sector. Along with this, there has been an escalating preference for personalized medicines that offer tailor-made therapies to individual patients. Facilitated by the increasing focus on patient-centered approaches, this has created numerous opportunities for genetic medicine and novel technologies, thereby creating a positive outlook for the nucleic acid labeling market. The market is further driven by the rapid advancements in nanotechnology that has led to the continual developments across point-of-care (POC)-based nucleic acid detection. Some of the other factors further contributing to the market growth include the increasing research and development (R&D) activities in the field of genomic research and disease diagnosis and the rising healthcare expenditure across the globe.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global nucleic acid labelling market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, labeling type, method, application and sector.

Breakup by Product:

• Kits
• Reagents
• Instruments
   

Breakup by Labeling Type:

• Radioisotope/Radioactive Labels
• Non-Radioactive Labels
   

Breakup by Method:

• Enzyme-based
  • PCR
  • 5’ End Labeling
  • 3’ End Labeling
  • Others
• Chemical-based
  • Conjugation
  • Photoreaction
     

Breakup by Application:

• Oligonucleotide Labeling
• In-Situ Hybridization
• Southern and Northern Blotting
• Cellular Localization
• Others
   

Breakup by Sector:

• Diagnostics
• Therapeutics
• Research
   

Breakup by Region:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Cytiva (Danaher Corporation), Enzo Biochem Inc., F. Hoffmann LA-Roche AG (Roche Holding AG), Merck KGaA, New England Biolabs (UK) Ltd., PerkinElmer Inc., Promega Corporation, Thermo Fisher Scientific Inc. and Vector Laboratories.

Report Coverage:

Key Questions Answered in This Report:

• How has the global nucleic acid labelling market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global nucleic acid labelling market?
• What are the key regional markets?
• What is the breakup of the market based on the product?
• What is the breakup of the market based on the labeling type?
• What is the breakup of the market based on the method?
• What is the breakup of the market based on the application?
• What is the breakup of the market based on the sector?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global nucleic acid labelling market and who are the key players?
• What is the degree of competition in the industry?